T 细胞非霍奇金淋巴瘤的临床试验
总计14728个结果
-
Eisai Inc.National Cancer Institute (NCI); Tufts Medical Center; Ligand Pharmaceuticals完全的
-
Huijing WuBeijing Xisike Clinical Oncology Research Foundation; CSPC Pharmaceutical Group招聘中
-
The First Affiliated Hospital with Nanjing Medical...招聘中
-
The First Affiliated Hospital of Soochow University招聘中
-
Second Affiliated Hospital, School of Medicine,...Changhai Hospital; Shanxi Province Cancer Hospital; The First Affiliated Hospital of Anhui Medical... 和其他合作者招聘中
-
Astex Pharmaceuticals, Inc.主动,不招人复发/难治性外周 T 细胞淋巴瘤西班牙, 美国, 澳大利亚, 法国, 英国, 意大利, 波兰
-
Dizal Pharmaceuticals完全的
-
Samsung Medical CenterNational Cancer Center, Korea; Asan Medical Center; Severance Hospital完全的
-
Medical College of WisconsinMidwest Athletes Against Childhood Cancer尚未招聘淋巴瘤 | 白血病 | 霍奇金病 | CD30 阳性弥漫性大 B 细胞淋巴瘤 | CD30+间变性大细胞淋巴瘤 | CD30+ 多形性大 T 细胞皮肤淋巴瘤 | CD30+ 免疫母细胞大 T 细胞皮肤淋巴瘤美国
-
Yale UniversitySidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Massey Cancer Center撤销
-
Tianjin Medical University Cancer Institute and...CSPC Ouyi Pharmaceutical Co., Ltd.尚未招聘
-
Peking Union Medical College HospitalCSPC Ouyi Pharmaceutical Co., Ltd.招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.尚未招聘
-
Sun Yat-sen University招聘中Natural Killer T-cell Lymphoma中国
-
Seagen Inc.主动,不招人
-
Spectrum Pharmaceuticals, Inc终止外周T细胞淋巴瘤比利时, 西班牙, 美国, 澳大利亚, 法国, 以色列, 加拿大, 英国, 新西兰, 意大利, 爱尔兰, 波兰, 波多黎各
-
Fondazione Italiana Linfomi ONLUS完全的
-
Lymphoma Study AssociationJanssen-Cilag International NV完全的
-
National Cancer Centre, Singapore终止
-
Liling ZhangCSPC Ouyi Pharmaceutical Co., Ltd.招聘中
-
Peking Union Medical College HospitalBeijing Longfu Hospital尚未招聘
-
Tianjin Medical University Cancer Institute and...邀请报名
-
Samsung Medical Center未知
-
Won Seog KimSanofi招聘中自然杀伤/T 细胞淋巴瘤 | 复发性自然杀伤/T 细胞淋巴瘤 | 难治性自然杀伤/T 细胞淋巴瘤大韩民国
-
SethiMerck Sharp & Dohme LLC招聘中
-
Shanghai Pudong HospitalUTC Therapeutics Inc.撤销急性髓系白血病 (AML) | 多发性骨髓瘤 (MM) | B 细胞非霍奇金淋巴瘤 (B-NHL) | T 细胞白血病/淋巴瘤,成人 | B 细胞急性淋巴细胞白血病 (B-ALL)中国
-
Navy General Hospital, BeijingChinese PLA General Hospital招聘中
-
The Lymphoma Academic Research OrganisationCelgene主动,不招人复发性血管免疫母细胞性 T 细胞淋巴瘤 | 难治性血管免疫母细胞性 T 细胞淋巴瘤法国, 丹麦, 英国, 奥地利, 比利时